Transact Technologies TACT Deferred Tax Assets, Valuation Allowance

Deferred Tax Assets, Valuation Allowance at other companies

Cineverse Corp.CNVS

$31.36M+0.7%

Envoy MedicalCOCH

$654K+2.5%

State StreetSTT

$198M+15.1%

OFG BancorpOFG

$568K-87.9%

BKBK

$127M-5.9%

PepsiCoPEP

$6.12B-1.1%

Other financials

Income statement

See full

Revenue$14.4M+10.4%

Gross profit$7.3M+14.1%

Operating income$771.0K+5,240%

Net income$766.0K+3,932%

EPS (diluted)$0.07—

Balance sheet

See full

Cash & equivalents$18.8M+32.9%

Total debt$3.4M+255%

Total equity$32.3M+4.4%

Total assets$47.9M+8.4%

Cash flow

See full

Operating cash flow-$946.0K-488%

CapEx$80.0K+700%

Free cash flow-$1.0M-500%

Valuation

See full

Market cap$60.01M+42.0%

Enterprise value$44.54M+86.4%

P/S1.1×+0.3×

Profitability

See full

Gross margin49%+0.5pp

Operating margin-1.2%-0.5pp

Net margin-0.9%-0.5pp

FCF margin12.7%—

Returns & leverage

See full

Return on equity-1.6%-0.8pp

Debt / equity0.1×+0.1×

Current ratio3.1×+0.1×

Where this comes from

Reported directly by Transact Technologies in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsValuationAllowance.

The official record: Transact Technologies’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Transact Technologies's deferred tax assets, valuation allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Transact Technologies's deferred tax assets, valuation allowance?: Transact Technologies (TACT) reported deferred tax assets, valuation allowance of $8.5M in Q1 2026.
How has Transact Technologies's deferred tax assets, valuation allowance changed year-over-year?: Transact Technologies's deferred tax assets, valuation allowance increased by 2.4% year-over-year, from $8.3M to $8.5M.